| Dr Stephanie Anne Garozzo, MD | |
|
40 Hart St, Bldg A - 2nd Flr, New Britain, CT 06052-1743 | |
| (860) 224-2447 | |
| (860) 826-5845 |
| Full Name | Dr Stephanie Anne Garozzo |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 18 Years |
| Location | 40 Hart St, New Britain, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093973703 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 048740 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Hospital Of Central Connecticut | New britain, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians For Women's Health, Llc | 3274430665 | 278 |
News Archive
GW Cancer Research Team in the Department of Biochemistry and Molecular Biology, in the School of Medicine and Health Sciences, published a study that is the first of its kind to use mRNA sequencing to look at the expression of genome, at a unprecedented resolution at the current time, in three types of breast cancer.
Researchers have recently claimed that eosinophilic chronic sinusitis is an immune disorder caused by the body's reaction to fungus.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced the results of a study evaluating the activity of elesclomol against acute myeloid leukemia (AML) cell lines and primary leukemic blast cells from AML patients, presented at the Annual Meeting of the American Society of Hematology (ASH) in New Orleans.
The U.S. Department of Health and Human Services (HHS), the Association for Professionals in Infection Control and Epidemiology (APIC), and the Society for Healthcare Epidemiology of America (SHEA) today recognized the Saint Raphael Campus of Yale New Haven Hospital with the 2012 Partnership in Prevention Award for achieving the greatest sustainable improvements towards eliminating healthcare-associated infections (HAIs).
› Verified 3 days ago
| Entity Name | Physicians For Women's Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801826680 PECOS PAC ID: 3274430665 Enrollment ID: O20031215000455 |
News Archive
GW Cancer Research Team in the Department of Biochemistry and Molecular Biology, in the School of Medicine and Health Sciences, published a study that is the first of its kind to use mRNA sequencing to look at the expression of genome, at a unprecedented resolution at the current time, in three types of breast cancer.
Researchers have recently claimed that eosinophilic chronic sinusitis is an immune disorder caused by the body's reaction to fungus.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced the results of a study evaluating the activity of elesclomol against acute myeloid leukemia (AML) cell lines and primary leukemic blast cells from AML patients, presented at the Annual Meeting of the American Society of Hematology (ASH) in New Orleans.
The U.S. Department of Health and Human Services (HHS), the Association for Professionals in Infection Control and Epidemiology (APIC), and the Society for Healthcare Epidemiology of America (SHEA) today recognized the Saint Raphael Campus of Yale New Haven Hospital with the 2012 Partnership in Prevention Award for achieving the greatest sustainable improvements towards eliminating healthcare-associated infections (HAIs).
› Verified 3 days ago
| Entity Name | The Hospital Of Central Connecticut At New Britain General And Bradley |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063461481 PECOS PAC ID: 6507776564 Enrollment ID: O20040115000497 |
News Archive
GW Cancer Research Team in the Department of Biochemistry and Molecular Biology, in the School of Medicine and Health Sciences, published a study that is the first of its kind to use mRNA sequencing to look at the expression of genome, at a unprecedented resolution at the current time, in three types of breast cancer.
Researchers have recently claimed that eosinophilic chronic sinusitis is an immune disorder caused by the body's reaction to fungus.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced the results of a study evaluating the activity of elesclomol against acute myeloid leukemia (AML) cell lines and primary leukemic blast cells from AML patients, presented at the Annual Meeting of the American Society of Hematology (ASH) in New Orleans.
The U.S. Department of Health and Human Services (HHS), the Association for Professionals in Infection Control and Epidemiology (APIC), and the Society for Healthcare Epidemiology of America (SHEA) today recognized the Saint Raphael Campus of Yale New Haven Hospital with the 2012 Partnership in Prevention Award for achieving the greatest sustainable improvements towards eliminating healthcare-associated infections (HAIs).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephanie Anne Garozzo, MD 40 Hart St, Bldg A - 2nd Flr, New Britain, CT 06052-1743 Ph: (860) 224-2447 | Dr Stephanie Anne Garozzo, MD 40 Hart St, Bldg A - 2nd Flr, New Britain, CT 06052-1743 Ph: (860) 224-2447 |
News Archive
GW Cancer Research Team in the Department of Biochemistry and Molecular Biology, in the School of Medicine and Health Sciences, published a study that is the first of its kind to use mRNA sequencing to look at the expression of genome, at a unprecedented resolution at the current time, in three types of breast cancer.
Researchers have recently claimed that eosinophilic chronic sinusitis is an immune disorder caused by the body's reaction to fungus.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced the results of a study evaluating the activity of elesclomol against acute myeloid leukemia (AML) cell lines and primary leukemic blast cells from AML patients, presented at the Annual Meeting of the American Society of Hematology (ASH) in New Orleans.
The U.S. Department of Health and Human Services (HHS), the Association for Professionals in Infection Control and Epidemiology (APIC), and the Society for Healthcare Epidemiology of America (SHEA) today recognized the Saint Raphael Campus of Yale New Haven Hospital with the 2012 Partnership in Prevention Award for achieving the greatest sustainable improvements towards eliminating healthcare-associated infections (HAIs).
› Verified 3 days ago
Xun C Zhou, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 40 Hart St, Building D, Lower Level, New Britain, CT 06052 Phone: 860-826-1101 Fax: 860-826-1845 | |
Lisa Rinaldi, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 300 Kensington Ave, New Britain, CT 06051 Phone: 860-224-6200 | |
Dr. Rachel Lamonica, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 Grand St, New Britain, CT 06052 Phone: 860-224-5467 Fax: 860-224-5472 | |
Dr. Anna Lyapis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 Grand St, New Britain, CT 06052 Phone: 860-224-5261 | |
Joseph A Welna, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3 Rockridge Rd, New Britain, CT 06052 Phone: 860-224-1096 | |
Dr. Narendra Tohan, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 33 Lexington St, New Britain, CT 06052 Phone: 860-826-5122 Fax: 860-673-6721 |